Department of Orthopaedics and Traumatology, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China.
Foot Ankle Int. 2013 Apr;34(4):550-6. doi: 10.1177/1071100713481432. Epub 2013 Mar 5.
Tricortical autograft has been commonly used in subtalar distraction arthrodesis (SDA) for severe calcaneal malunion. Structural allograft enriched with orthobiological agents is an alternative. This study was performed to evaluate the results of SDA using fresh-frozen allogeneic femoral head without the addition of orthobiological agents.
We retrospectively reviewed 15 consecutive SDA procedures (13 patients) with allogeneic femoral head augmented with local autograft for the treatment of severe calcaneal malunion. Clinical outcome was evaluated with the American Orthopaedic Foot & Ankle Society (AOFAS) ankle-hindfoot score, visual analog scale (VAS) pain score, Short Form-12 (SF-12), range of motion (ROM) of the ankle joint, and patient satisfaction rate. Radiographic assessment included the talar declination angle (TDA), calcaneal inclination angle (CIA), lateral talocalcaneal angle (LTCA), heel height, calcaneal length, and union time.
At a median follow-up of 36.0 months (range, 24-47 months), all 15 feet (100%) achieved union, at a median of 13.0 weeks (range, 12-18 weeks). The AOFAS score and VAS pain score improved significantly, with a satisfaction rate of 93.3%. The TDA, CIA, LTCA, and heel height improved significantly. The median increase in heel height was 8.6 mm (range, 1.9-20.1 mm). There was a significant reduction in calcaneal length. Complications included 1 varus malalignment, 1 complex regional pain syndrome, 1 hardware irritation, and 1 sural neuralgia.
This study found that SDA using fresh-frozen femoral head allograft without an orthobiological agent was cost-effective and may have outcomes comparable to those using autograft or allograft enriched with orthobiological agents.
三皮质自体移植物在距下关节撑开融合术(SDA)中常用于治疗严重的跟骨畸形愈合。富含骨科生物制剂的结构性同种异体移植物是另一种选择。本研究旨在评估不添加骨科生物制剂的新鲜冷冻同种异体股骨头用于 SDA 的结果。
我们回顾性分析了 15 例(13 例患者)连续 SDA 手术,使用同种异体股骨头和局部自体骨移植治疗严重的跟骨畸形愈合。临床结果采用美国矫形足踝协会(AOFAS)踝后足评分、视觉模拟评分(VAS)疼痛评分、SF-12 简表、踝关节活动范围(ROM)和患者满意度进行评估。影像学评估包括距骨倾斜角(TDA)、跟骨倾斜角(CIA)、外距跟骨角(LTCA)、跟骨高度、跟骨长度和愈合时间。
中位数随访 36.0 个月(范围 24-47 个月),所有 15 例(100%)均获得愈合,中位数为 13.0 周(范围 12-18 周)。AOFAS 评分和 VAS 疼痛评分显著改善,满意度为 93.3%。TDA、CIA、LTCA 和跟骨高度显著改善。跟骨高度的中位数增加 8.6 毫米(范围 1.9-20.1 毫米)。跟骨长度显著缩短。并发症包括 1 例内翻畸形、1 例复杂性区域疼痛综合征、1 例内固定刺激、1 例腓肠神经痛。
本研究发现,不添加骨科生物制剂的新鲜冷冻同种异体股骨头 SDA 具有成本效益,其结果可能与使用自体移植物或富含骨科生物制剂的同种异体移植物相当。